1Minerals Corp. | WebDisclosure

COMMUNIQUÉ DE PRESSE

publié le 24/01/2024 à 15:00, il y a 1 année 10 mois

1Minerals Corp Secures North America's Largest Lithium Portfolio
1Minerals Corp, a leader in the lithium mining industry, has secured North America's largest grassroots lithium portfolio, covering over 820,000 hectares across more than 100 projects in Quebec. This significant achievement reinforces the company's commitment to advancing the global clean energy transition and securing critical Canadian and North American lithium reserves. The company's strategic portfolio positioning, Quebec's emergence as the epicenter of North America's lithium revolution, and notable partnerships underscore their crucial role in lithium exploration. As the world accelerates its transition to clean energy solutions, the press release emphasizes the soaring demand for lithium and the strategic importance of securing essential minerals for Canada and North America, underscoring 1Minerals' unique position and commitment to resource development. The release also provides insights into the valuation comparison and market position, global comparisons with notable lithium exploration companies in Quebec, and major investments by significant industry players in the province. The press release also highlights the expected growth in EV adoption and the challenges in meeting the soaring demand for lithium. Notably, the company's forward-looking statement and cautionary statement on future anticipated results and market position reflect prudent transparency and industry understanding. The comprehensive press release offers valuable insights into 1Minerals Corp's leadership, strategic positioning, and industry potential, making it a crucial read for stakeholders, industry professionals, and investors.

Clean Energy Transition Lithium Mining Industry North America Lithium Portfolio Quebec Lithium Exploration EV Adoption And Lithium Demand

Publié le 04/12/2025 à 18:14, il y a 13 heures 38 minutes

Résiliation d'une convention conclue entre actionnaires
Publié le 04/12/2025 à 18:00, il y a 13 heures 53 minutes

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Publié le 04/12/2025 à 18:00, il y a 13 heures 53 minutes

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Publié le 04/12/2025 à 17:45, il y a 14 heures 8 minutes

Informations relatives au nombre total de droits de vote et d’actions
Publié le 04/12/2025 à 17:45, il y a 14 heures 8 minutes

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

Voir tout LES ECHOS COMFI WIRE

Publié le 05/12/2025 à 02:35, il y a 5 heures 18 minutes

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Publié le 05/12/2025 à 02:30, il y a 5 heures 23 minutes

Klondike Gold Announces AGM Results
Publié le 05/12/2025 à 01:00, il y a 6 heures 53 minutes

BEACN Closes First Tranche of Non-Brokered Private Placement
Publié le 04/12/2025 à 23:05, il y a 8 heures 48 minutes

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Publié le 04/12/2025 à 23:00, il y a 8 heures 53 minutes

NXT Energy Solutions Completes Data Acquisition for SFD Survey

Voir tout ACCESSWIRE

Publié le 05/12/2025 à 07:00, il y a 52 minutes

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Publié le 05/12/2025 à 03:30, il y a 4 heures 22 minutes

CGTN: What makes cooperation between China and France a two-way success
Publié le 04/12/2025 à 23:50, il y a 8 heures 2 minutes

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Publié le 04/12/2025 à 20:25, il y a 11 heures 27 minutes

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Publié le 04/12/2025 à 20:15, il y a 11 heures 38 minutes

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Voir tout EQS

News